Paysign Inc. logo

Paysign Inc. (PAYS)

Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
8. 55
-0.18
-2.0619%
$
486.38M Market Cap
36.25 P/E Ratio
- Div Yield
321,600 Volume
0.05 Eps
$ 8.73
Previous Close
Add Transaction
Day Range
8.4 8.79
Year Range
3.08 9.3
Want to track PAYS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

PAYS closed today lower at $8.55, a decrease of -2.0619% from yesterday's close, completing a monthly increase of 16.8033% or $1.23. Over the past 12 months, PAYS stock gained 65.6977%.
PAYS is not paying dividends to its shareholders.
The last earnings report, released on May 07, 2026, missed the consensus estimates by -0.03%. On average, the company has fell short of earnings expectations by -0.0167%, based on the last three reports.
Paysign Inc. has completed 2 stock splits, with the recent split occurring on Dec 30, 2005.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

PAYS Chart

People also search for

Apex Treasury Corporation Units
$ 10.23
0%
PGY
Pagaya Technologies Ltd.
$ 17.15
-1.944%
Paya Holdings Inc
$ 9.74
0%
Pagaya Technologies Ltd.
$ 0.03
+1.7422%
Eos Energy Enterprises Inc.
$ 4.13
+4.2929%
Paysign, Inc. (PAYS) Q1 2026 Earnings Call Transcript

Paysign, Inc. (PAYS) Q1 2026 Earnings Call Transcript

Paysign, Inc. (PAYS) Q1 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
Paysign Q1 Earnings Call Highlights

Paysign Q1 Earnings Call Highlights

Paysign NASDAQ: PAYS reported what executives described as the strongest start to a year in the company's history, with first-quarter 2026 revenue rising 50.8% year over year to $28 million and profitability expanding sharply as its patient affordability business became its largest revenue contributor.

Marketbeat | 2 months ago
Paysign: The Market Is Finally Repricing A Pharma Margin Story

Paysign: The Market Is Finally Repricing A Pharma Margin Story

Paysign is evolving beyond a niche prepaid card processor, with patient affordability now driving higher-margin growth. 2025 results highlight a 40.5% revenue increase to $82M, with pharma revenue surging to $33.9M and gross margin expanding to 59.4%. PAYS trades above peer sales multiples, reflecting its shift to a high-value workflow business, while price-to-cash flow remains attractive if cash conversion holds.

Seekingalpha | 3 months ago

Paysign Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
PF
Phillip Fitzsimmons Hennion & Walsh Asset Management Inc.
56,395 $351,553.92 $485,842.92 $134,289 38.2%
Joseph Castro
Joseph Castro Nuveen LLC
73,501 $407,840.87 $634,879.59 $227,038.72 55.67%
RS
Richard Slavik Newbridge Financial Services Group Inc.
300 $1,545 $2,595 $1,050 67.96%
Jennifer Grunberg
Jennifer Grunberg Allspring Global Investments Holdings LLC
65,853 $454,696.2 $557,919.79 $103,223.59 22.7%
Bobby Adusumilli
Bobby Adusumilli SJS Investment Consulting Inc.
105 $652.65 $889.58 $236.93 36.3%

Paysign Inc. (PAYS) FAQ

What is the stock price today?

The current price is $8.55.

On which exchange is it traded?

Paysign Inc. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is PAYS.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 486.38M.

Has Paysign Inc. ever had a stock split?

Paysign Inc. had 2 splits and the recent split was on Dec 30, 2005.

Paysign Inc. Profile

Transportation Infrastructure Industry
Industrials Sector
Mark Newcomer CEO
NASDAQ (CM) Exchange
70451A104 CUSIP
US Country
226 Employees
- Last Dividend
30 Dec 2005 Last Split
2 Apr 1998 IPO Date

Overview

Paysign, Inc. specializes in offering a broad spectrum of prepaid card programs, patient affordability options, digital banking services, and integrated payment processing for a diverse clientele including businesses, consumers, and government institutions. Initially known as 3PEA International, Inc., the company underwent a name change to Paysign, Inc. in April 2019, showcasing its evolution and broadening its focus. Founded in 1995 and operating from its headquarters in Henderson, Nevada, Paysign extends its market presence primarily towards organizations and municipalities in need of efficient payment solutions for various purposes such as rewards, rebates, and payment assistance. This rebranding and strategic positioning reflect Paysign's commitment to innovation in payment solutions.

Products and Services

  • Prepaid Card Programs: Offers an array of prepaid solutions including corporate rewards, prepaid gift cards, and general-purpose reloadable debit cards. These are tailored for corporations seeking streamlined methods for distributing rewards, consumer rebates, and more efficient payroll disbursement.
  • Patient Affordability Offerings: Specializes in healthcare-related payment solutions like pharmacy payment assistance and healthcare reimbursement payments. These services aim to facilitate smoother transactions within the healthcare industry, ensuring that patients can afford their medications and treatments through innovative payment solutions.
  • Digital Banking Services: Provides digital banking solutions, including demand deposit accounts that come with a debit card, enabling easier access to funds. This service is designed for both individuals and businesses in need of straightforward, reliable banking and payment options.
  • Integrated Payment Processing: Offers comprehensive payment processing services that cater to a wide range of transaction needs for businesses, governments, and individual consumers. This includes processing for various types of payments and transfers, ensuring secure and efficient financial operations.
  • Employee Incentives and Consumer Rebates: Delivers customized solutions for organizations to provide incentives to employees or rebates to consumers effectively. These programs are crafted to enhance motivation and satisfaction, contributing to better engagement and consumer loyalty.
  • Donor Compensation and Clinical Trials: Provides specialized payment solutions for compensating donors and managing financial transactions related to clinical trials. These services are particularly geared towards organizations in the biomedical and pharmaceutical sectors, requiring precise and ethical handling of payments.

Contact Information

Address: 2615 St. Rose Parkway
Phone: 702 453 2221